Chapter 1: Curcumin is excellent compound for various medicinal usages

Similar documents
UNIVERSITY TEKNOLOGI MARA THE ANTI PROLIFERATIVE PROPERTIES OF TINOSPORA CRISPA ON TRIPLE NEGATIVE BREAST CANCER CELL LINES

Introduction. Cancer Biology. Tumor-suppressor genes. Proto-oncogenes. DNA stability genes. Mechanisms of carcinogenesis.

T cell maturation. T-cell Maturation. What allows T cell maturation?

C-Phycocyanin (C-PC) is a n«sjfc&c- waefc-jduble phycobiliprotein. pigment isolated from Spirulina platensis. This water- soluble protein pigment is

ciap using fragment based drug discovery

Apoptosis Mediated Cytotoxicity of Curcumin Analogues PGV-0 and PGV-1 in WiDr Cell Line

Type of file: PDF Size of file: 0 KB Title of file for HTML: Supplementary Information Description: Supplementary Figures

Diseases of Immunity 2017 CL Davis General Pathology. Paul W. Snyder, DVM, PhD Experimental Pathology Laboratories, Inc.

Innate Immunity, Inflammation and Cancer

Antiangiogenesis - Immune Therapy Combinations. George Coukos, MD, PhD Heinz Zwierzina, MD

Chemistry of Carbon. Building Blocks of Life

p53 and Apoptosis: Master Guardian and Executioner Part 2

Immunology CANCER IMMUNOLOGY

BL-8040: BEST-IN-CLASS CXCR4 ANTAGONIST FOR TREATMENT OF ONCOLOGICAL MALIGNANCIES. Overview and Mechanism of Action Dr.

Challenges in Establishing Potent Cancer Chemotherapy Using Newly Synthesized 1,5-Diaryl-3-Oxo-1,4- Pentadiene Analogs of Curcumin

Index. neurosurgery.theclinics.com. Note: Page numbers of article titles are in boldface type.

CELL BIOLOGY - CLUTCH CH CANCER.

Journal Club: The Use of Fish Oil Lipid Emulsion for Gastrointestinal Surgery Patients

Micro RNA Research. Ken Kosik. Harriman Professor, Department of Molecular, Cellular & Developmental Biology and Biomolecular Sciences & Engr.

EBV infection B cells and lymphomagenesis. Sridhar Chaganti

Developing Best in Class BET Inhibitors for Oncology & AI: from Discovery to the Clinic. Kevin G. McLure, PhD EpiCongress July 2014

IVC History, Cancer Research

Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies. Michael A. Curran, Ph.D.

Understanding the mechanisms of asbestos related diseases

ulcer healing role 118 Bicarbonate, prostaglandins in duodenal cytoprotection 235, 236

CANCER THERAPEUTICS: A NOVEL APPROACH

Genetics and Cancer Ch 20

Dr. C. Tom Kouroukis. New and upcoming treatments for Lymphoma

Innate Immunity and Inflammation

PI3K Background. The SignalRx R & D pipeline is shown below followed by a brief description of each program:

HDAC Inhibitors and PARP inhibitors. Suresh Ramalingam, MD Associate Professor Chief of Thoracic Oncology Emory University School of Medicine

Cancer Genetics. What is Cancer? Cancer Classification. Medical Genetics. Uncontrolled growth of cells. Not all tumors are cancerous

Cytokine Arrays Reveal Black Ops Tactics of Tumor-induced Immunosuppression

BIT 120. Copy of Cancer/HIV Lecture

Medical Facts of Aronia. Steven Saulsbury M.D. February

Molecular biology :- Cancer genetics lecture 11

NKTR-255: Accessing IL-15 Therapeutic Potential through Robust and Sustained Engagement of Innate and Adaptive Immunity

Glioma cancer stem cells mediate immune suppression that can be reversed with STAT3 blockade

WHY TARGETTING SIGNALLING PATHWAYS?

Engineered Immune Cells for Cancer Therapy : Current Status and Prospects

Introduction: 年 Fas signal-mediated apoptosis. PI3K/Akt

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation

Treating patients affordably: personalized medicine in India

Nonspecific External Barriers skin, mucous membranes

What is survivorship? Late effects of treatment. Concerns of survivorship

Tolerance, autoimmunity and the pathogenesis of immunemediated inflammatory diseases. Abul K. Abbas UCSF

Crosstalk between Adiponectin and IGF-IR in breast cancer. Prof. Young Jin Suh Department of Surgery The Catholic University of Korea

BIMM134 The Biology of Cancer SPRING 2015

Objectives. Abbas Chapter 11: Immunological Tolerance. Question 1. Question 2. Question 3. Definitions

A Computational Assessment of the Robustness of Cancer Treatments with Respect to Immune Response Strength, Tumor Size and Resistance

Signaling Apoptosis. Scott André Oakes, M.D. Dept. of Pathology Univ. of Calif-San Francisco. Cyt c Release BAX/BAK. Apoptosome Formation

Immuno-Oncology. Axel Hoos, MD, PhD Senior Vice President, Oncology R&D. February 24, 2016

Yong Wu, Ph.D. Division of Cancer Research and Training (DCRT) Charles R. Drew University of Medicine & Science

IDENTIFICATION OF BIOMARKERS FOR EARLY DIAGNOSIS OF BREAST CANCER"

Scott Abrams, Ph.D. Professor of Oncology, x4375 Kuby Immunology SEVENTH EDITION

Virchow s Hypothesis lymphorecticular infiltration of cancer reflected the origin of cancer at sites of inflammation

Basis and Clinical Applications of Interferon

Antitumor Activity of CUDC-305, a Novel Oral HSP90 Inhibitor, in Solid and Hematological Tumor Xenograft Models

CANCER IMMUNOPATHOLOGY. Eryati Darwin Faculty of Medicine Andalas University

Instructor: Eric Bennett, Ph.D. - Office Hours: Tuesday and Thursday 3-4 pm, Natural Sciences Building, Room 5316

Biologics Effects of Targeted Therapeutics

CYTOKINE RECEPTORS AND SIGNAL TRANSDUCTION

NKTR-255: Accessing The Immunotherapeutic Potential Of IL-15 for NK Cell Therapies

The TNF & TNF receptor superfamillies

Summary of Evolution and the Requirements for the Specific Cure of Cancer

Chapter 9, Part 1: Biology of Cancer and Tumor Spread

Deregulation of signal transduction and cell cycle in Cancer

CANCER 1.7 M 609,000 26% 15.5 M 73% JUST THE FACTS. More Than 1,100 Cancer Treatments in Clinical Testing Offer Hope to Patients

Immunology Lecture 4. Clinical Relevance of the Immune System

IVC History, Cancer Research

Discovery and Optimization of Inhibitors of STAT3 Activation for the Treatment of Squamous Cell Carcinoma of the Head and Neck

Neoplasia 18 lecture 6. Dr Heyam Awad MD, FRCPath

National Cancer Institute 1

What are Clinical Trials

Cancer. The fundamental defect is. unregulated cell division. Properties of Cancerous Cells. Causes of Cancer. Altered growth and proliferation

Kentucky Lung Cancer Research Program. Cycle 6 Grant Abstracts

Biobehavioral Pathways in Epithelial Ovarian Cancer

UNIVERSITY OF MEDICINE AND PHARMACY CRAIOVA PhD SCHOOL. PhD THESIS

Understanding the cellular targets of IMiDs and the relevance to clinical efficacy Dr. A. Keith Stewart

CELL BIOLOGY - CLUTCH CH THE IMMUNE SYSTEM.

Novel Approaches to CAR-T Cell Platform

The Immune System: The Mind Body Connection. Presented by Margaret Kemeny, Ph.D. Department of Psychiatry, University of California, San Francisco

Contents. Preface XV Acknowledgments XXI List of Abbreviations XXIII About the Companion Website XXIX

BIO360 Fall 2013 Quiz 1

METASTATIC COLORECTAL CANCER: TUMOR MUTATIONAL ANALYSIS AND ITS IMPACT ON CHEMOTHERAPY SUMA SATTI, MD

Effector mechanisms of cell-mediated immunity: Properties of effector, memory and regulatory T cells

Author: Christine Thuyvan Dinh, M.D. Mentors: Thomas Van De Water, Ph.D., Fred Telischi, M.D., Simon Angeli, M.D.

Nursing s Role in the Management of New Oral Chemotherapy Agents

Phospho-AKT Sampler Kit

Immunology - Lecture 2 Adaptive Immune System 1

Involvement of TLR4/STAT3 signaling in the antimelanoma effects of atractylenolide II. Fu Xiuqiong

THE ROLE OF TARGETED THERAPY AND IMMUNOTHERAPY IN THE TREATMENT OF ADVANCED CERVIX CANCER

Generation of post-germinal centre myeloma plasma B cell.

T Cell Effector Mechanisms I: B cell Help & DTH

Adaptive Immune Response Day 2. The Adaptive Immune Response

MOLECULAR BASIS OF ONCOGENESIS

"BRCAness," PARP and the Triple-Negative Phenotype

Karyotype analysis reveals transloction of chromosome 22 to 9 in CML chronic myelogenous leukemia has fusion protein Bcr-Abl

Apoptosis Oncogenes. Srbová Martina

Self Tolerance and MHC Restriction. Dr. Issa Abu-Dayyeh

Transcription:

Super-Curcumin Story Chapter 1: Curcumin is excellent compound for various medicinal usages Chapter 2: Discovery of Super-Curcumin analog Chapter 3: Anti-tumor activities of Super-Curcumin analog Chapter 4: Molecular targets of analogs Chapter 5: Oncogenes & analogs Chapter 6: Apoptosis & analogs Chapter 7: Cancer stem cells & analogs Chapter 8: Analogs lead drug discovery Supplement: Super-Curcumin analog & Sleeping sickness (African trypanosomiasis)

Chapter 1: Curcumin is excellent compound for various medicinal usages Curcumin We can eat it! IUPAC name; (1E,6E)-1,7-bis (4-hydroxy-3-methoxyphenyl) -1,6- heptadiene-3,5-dione Curcumin is a multi-targeted compound Defeat all enemies! Cur Curcumin can stop the individual gears of wheels in cancer. Curcumin man

Why does curcumin have a multiplicity of targets? Michael reaction High affinity to proteins via a thiol group Protein

How can curcumin control multiple targets? Resilience Pros Cons curcumin Well balanced Healthy Pros Cons Molar ratio Ex) Anti oncogene Th1 Ex) Oncogene Th2 Cancer Infection Inflammation Alzheimer Tumor immune tolerance Resilience Recovery of health

Chapter 2: Discovery of Super-Curcumin analog Collaborator; Dept. Organic Chemistry, Graduate School of Pharmaceutical Science Tohoku Univ. Analog screening was started from the chemical library stored in Dept., Organic Chem.

Chapter 3: Anti-tumor activities of Super-Curcumin analog 0 > 50 16 89 spiecies of analogs types of cancer cell lines Over 100 species of analogs were synthesized from one lead compound, and the anti-tumor activities against 16 types of cancer cell lines were examined. Analogs can kill the cancer cells at concentrations 30 60 times lower than 5-FU, cisplatin, irinotecan. Analogs bearing strong anti-tumor activities They have a 84 times stronger activity than Curcumin.

Chapter 4: Molecular targets of analogs Analogs have different mechanisms from approved cytotoxics. This structure is important. GO 035 IC 50 : 1.6 M Stronger anti-tumor activities >> GO Y041 IC 50 : >100 M No anti-tumor activities Michael reaction No affinity to High affinity to Targeted to Oncogene products (protein) DNA

Analogs target oncogene products. Malignant phenotypes 1. Loss of growth control 2. Resistance to apoptosis 3. Immortality 4. Angiogenesis 5. Invasion 6. Metasatasis Chapter 5: Oncogenes & analog Her2 inhibitor Myc inhibitor Analogs can regulate overexpressed oncogene products such as,,,. c-myc, KRAS, CyclinD1, ErbB2, β-catenin, COX-2,, (examined). KRAS inhibitor NF-kB inhibitor

Analogs can induce apoptosis. Malignant phenotypes Chapter 6: Apoptosis & analogs Caspases induction 1. Loss of growth control 2. Resistance to apoptosis 3. Immortality 4. Angiogenesis 5. Invasion 6. Metasatasis Analogs can induce apoptosis related proteins such as,,,,,,,. Caspases, PARP, TP53, XIAP, DR5,, (examined). P53 induction control curcumin GO-Y030 Death receptor induction Apoptotic DLD-1 cells

Analogs can kill cancer stem cells. Cancer stem cell is like a queen bee. She is resistant to chemotherapy. Chapter 7: Cancer stem cells & analogs sensitive resistant Killer Queen Phosphorylation of STAT3 is characteristic to cancer stem cells. Analogs can bind phosphorylation site of STAT3, and inhibit STAT3 signaling. Analog Analogs can inhibit cancer stem cell growth in vivo. STAT3

Chapter 8: Potential against rare cancers

CTCL can be cured in animal model.

Rare cancers Multiple myeloma MTT Assay 50.0 GI50(μM) 40.0 30.0 20.0 RPMI8226 KMS12 U266 OPM2 10.0 0.0 Curcumin Y030 Y078 Melphalan Thalidomide 72hr treatment

Chapter 9: Anti-angiogenic potential of analogs

Chapter 10: Radioprotection

Chapter 11: 1. Improvement of solubility Curcumin is low bioavailable (insoluble in water, poor absorption).

2. Antibody-Drug Conjugate Antigen recognition site Papain digestion Michael addition reduction addition

Chapter 12: Future Directions 1. An analog was detected in curry. It is potent to suppress gastric cancer in vivo. control ** * * * * ** analog * * * * Functional Food 2. Analogs could induce anti-tumor immunity, like curcumin. curcumin Increase CD4+ & CD8+ Increase Th1 cytokines Decrease Treg Decrease T cell apoptosis

Apendix (1): Patent Right We got US and Japan patents. Analog Analog man

Appendix (2): Analog & Sleeping sickness (African trypanosomiasis) Analogs may be effective for trypanosomiasis (sleeping sickness). Growth inhibition carried by mosquitoes Analogs Anti-trypanosomia activity Cytotoxicity Safety Index Recruit Collaborators!!